Publications
- Cytotoxic therapy of castration refractory prostate cancer2011 | First Faculty of Medicine
- Prognostic value of clinico-pathological factors in patiens with TAT1 baldder carcinoma2011 | First Faculty of Medicine
- Circulating tumor cells as a biomarker for the patients with castration resistant prostate cancerPublication without faculty affiliation
- Prognostic significance of circulating tumor cells in castration resistant prostate cancerPublication without faculty affiliation
- Circulation tumor cells in castration resistant prostate cancerPublication without faculty affiliation
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | First Faculty of Medicine, Second Faculty of Medicine
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum2023 | First Faculty of Medicine, Second Faculty of Medicine
- Serum Thymidine Kinase 1 - Potential Prostate Cancer Biomarker: A Clinical Study2023 | First Faculty of Medicine, Second Faculty of Medicine
- Overview of serum markers of prostate cancer2023 | First Faculty of Medicine
- Prognostic factors in metastatic prostate cancer2023 | First Faculty of Medicine
Loading network view...